The price of Accu-Chek® Instant 50 strips will reduce to £5.95

Roche today announced that the cost of the Accu-Chek Instant 50 strips will be reduced to £5.95.

The strips previously cost £7.50, and the reduction is anticipated to come into effect on 1st September 2023. It is hoped that the price reduction will ensure that the Accu-Chek Instant meter can be made available to more people with diabetes, to support them in their diabetes management.

The Accu-Chek Instant system is a "connected" blood glucose monitoring (BGM) system, featuring Bluetooth® enabled connectivity, which allows for wireless transfer of blood glucose results to the mySugr®†app. Data from the mySugr mobile app can also seamlessly be shared with healthcare professionals via the RocheDiabetes Care Platform, in near real-time. The Accu-Chek Instant system supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM).

Sean Gaffney, General Manager at Roche Diabetes Care commented; “At Roche Diabetes Care we constantly strive to make sure that we work in partnership with the NHS, to serve healthcare professionals and, ultimately, people with diabetes. Our focus is centered around providing support to healthcare professionals, and developing digital solutions to solve some of the daily challenges involved with patient care.

It is clear that pricing, within the self-monitoring blood glucose segment, has become increasingly important. As a business, we endeavor to remain competitive whilst continuing to work in partnership with the NHS.

We believe the combination of the Accu-Chek Instant Meter and its free of charge connectivity to the mySugr app and the RocheDiabetes Care Platform, provides patients and healthcare professionals with real value. Feedback from HCPs^1-3 has shown that by using these products and solutions, it has enabled them to deliver care more efficiently, and increase capacity, thereby saving time and costs.”

*Based on drug tariff price submission, submitted 21st July 2023

†The mySugr logbook is licensed for people with diabetes over the age of 16 years. The mySugr Bolus Calculator is licensed for people with diabetes over the age of 18 years.

1-3 Based on individual case studies carried out in local diabetes services (1. Preston; 2. Sunderland; 3. Hatfield) with healthcare professionals as part of consultancy agreements with Roche Diabetes Care.

Case studies are based on single center experiences, your experiences and opinions may vary.

About Roche Diabetes Care

Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.

Roche Diabetes Care is a global leader in integrated Personalised Diabetes Management (iPDM),  a holistic, patient-centred therapeutic approach with the ultimate goal of personalising diabetes management to streamline care and improve clinical outcomes. iPDM helps strengthen the care process, facilitates communication between patients and their healthcare team, and integrates tools that visualise and analyse data.

Under the brands Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value.

The RocheDiabetes Care Platform is a cloud-based diabetes management platform, which brings together diabetes information including blood glucose and insulin data from various devices within a single solution.

Since 2017, mySugr, one of the most popular diabetes management apps, has been part of Roche Diabetes Care.

For more information, please visit www.accu-chek.co.uk, www.accu-chek.ie and www.mysugr.com. Healthcare professionals can visit diabetes.roche.com/hcp-gb/.